ghk cu peptide effects research Frontiers GHK-Cu Peptide | Benefits, Dosage,
Description
Not much is known about DSIP synthesis
The honest summary is thinner than that list makes it sound, because no long-term human safety study has been run
Phase 2 weight loss (48 weeks): 22.8% at 8 mg maintenance 12 mg Weeks 13+ Maximum trial dose
It includes cycles and stages
Immunogen: Met1~Val134
Mild side effects such as slight redness or tenderness at the injection site may occur but usually resolve quickly
